AstraZeneca (LSE:AZN) Reports Positive Phase III Lung Cancer Trial Results
Never miss an important update on your stock portfolio and cut through the noise. Over 7 million investors…
AstraZeneca Halts Phase III Lung Cancer Trial as Drug Falls Short Against Keytruda — BigGo Finance
AstraZeneca has terminated a late-stage clinical trial for its experimental bispecific antibody volrustomig in metastatic non-small cell lung…
AstraZeneca reports Phase III survival benefit for Tagrisso–Orpathys lung cancer combination
Astra Zeneca logo on building ©Adobe Stock Images AstraZeneca (LSE:AZN) has reported positive results from the global Phase…
AstraZeneca touts Enhertu, Orpathys dual lung cancer wins amid bispecific failure
AstraZeneca reported positive results from two non-small cell lung cancer trials for Enhertu and an Orpathys-Tagrisso combination, although…
A merged AstraZeneca and BMS could lead Lilly on revenue until about 2030
In a potential marriage that analysts said faces long odds, AstraZeneca and Bristol Myers Squibb have held talks…
Abbisko, AstraZeneca to test lumipodlin with Tagrisso
SHANGHAI, July 1, 2026 /PRNewswire/ — Abbisko Therapeutics Co., Ltd. (“Abbisko Therapeutics” hereafter, HKEX code: 02256.HK) today announced…